Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zoltán Kis

Showing results (1-10 of 60) with videos related to

Pageof 6
Sort By:
Pharmaceutics|February 26, 2022
Stability Modelling of mRNA Vaccine Quality Based on Temperature Monitoring throughout the Distribution ChainZoltán Kis
The Review of Scientific Instruments|July 1, 2024
The redesigned neutron imaging facility, NORMA at BNC, BudapestZoltán Kis
Frontiers in Molecular Biosciences|December 6, 2024
Bacteriophage RNA polymerases: catalysts for mRNA vaccines and therapeuticsAdithya Nair, Zoltán Kis
Journal of Environmental Radioactivity|August 13, 2005
Review of dynamical models for external dose calculations based on Monte Carlo simulations in urbanised areasKatalin Eged, Zoltán Kis, Gabriele Voigt
Journal of Medical Microbiology|July 5, 2016
Countrywide dissemination of a DHA-1-type plasmid-mediated AmpC β-lactamase-producing Klebsiella pneumoniae ST11 international high-risk clone in Hungary, 2009-2013Zoltán Kis, Ákos Tóth, Laura Jánvári, et al.
Trends in Biotechnology|May 1, 2022
Quality by Design for enabling RNA platform production processesSimon Daniel, Zoltán Kis, Cleo Kontoravdi, et al.
Health Physics|June 6, 2002
Assessment of the aversion coefficient in nuclear safety in HungaryKatalin Eged, Béla Kanyár, Zoltán Kis, et al.
Biotechnology Journal|December 12, 2018
Emerging Technologies for Low-Cost, Rapid Vaccine ManufactureZoltán Kis, Robin Shattock, Nilay Shah, et al.
Vaccines|December 30, 2020
Resources, Production Scales and Time Required for Producing RNA Vaccines for the Global Pandemic DemandZoltán Kis, Cleo Kontoravdi, Robin Shattock, et al.
Vaccines|April 3, 2021
Correction: Kis, Z. et al. Resources, Production Scales and Time Required for Producing RNA Vaccines for the Global Pandemic Demand. <i>Vaccines</i> 2021, <i>9</i>, 3Zoltán Kis, Cleo Kontoravdi, Robin Shattock, et al.
Pageof 6

Showing results (1-10 of 60) with videos related to

Sort By:
Pageof 6
Pharmaceutics|February 26, 2022
Stability Modelling of mRNA Vaccine Quality Based on Temperature Monitoring throughout the Distribution ChainZoltán Kis
The Review of Scientific Instruments|July 1, 2024
The redesigned neutron imaging facility, NORMA at BNC, BudapestZoltán Kis
Frontiers in Molecular Biosciences|December 6, 2024
Bacteriophage RNA polymerases: catalysts for mRNA vaccines and therapeuticsAdithya Nair, Zoltán Kis
Journal of Environmental Radioactivity|August 13, 2005
Review of dynamical models for external dose calculations based on Monte Carlo simulations in urbanised areasKatalin Eged, Zoltán Kis, Gabriele Voigt
Journal of Medical Microbiology|July 5, 2016
Countrywide dissemination of a DHA-1-type plasmid-mediated AmpC β-lactamase-producing Klebsiella pneumoniae ST11 international high-risk clone in Hungary, 2009-2013Zoltán Kis, Ákos Tóth, Laura Jánvári, et al.
Trends in Biotechnology|May 1, 2022
Quality by Design for enabling RNA platform production processesSimon Daniel, Zoltán Kis, Cleo Kontoravdi, et al.
Health Physics|June 6, 2002
Assessment of the aversion coefficient in nuclear safety in HungaryKatalin Eged, Béla Kanyár, Zoltán Kis, et al.
Biotechnology Journal|December 12, 2018
Emerging Technologies for Low-Cost, Rapid Vaccine ManufactureZoltán Kis, Robin Shattock, Nilay Shah, et al.
Vaccines|December 30, 2020
Resources, Production Scales and Time Required for Producing RNA Vaccines for the Global Pandemic DemandZoltán Kis, Cleo Kontoravdi, Robin Shattock, et al.
Vaccines|April 3, 2021
Correction: Kis, Z. et al. Resources, Production Scales and Time Required for Producing RNA Vaccines for the Global Pandemic Demand. <i>Vaccines</i> 2021, <i>9</i>, 3Zoltán Kis, Cleo Kontoravdi, Robin Shattock, et al.
Pageof 6